Fortitude Mining and HeartSciences announced a definitive all-stock merger expected to close in H2 2026, with the new entity trading on Nasdaq as TUDE. The venture mining platform will incorporate HeartSciences' AI ECG capabilities under a healthcare unit led by Andrew Simpson, while DCG will own roughly 95% of the combined company. The deal preserves Zcash exposure as Fortitude’s core asset, creating a cross-industry public vehicle but with notable ownership concentration and closing risks.
The all-stock structure and 95% DCG ownership imply limited immediate upside for HSCS; close-dependent valuation and potential post-close trading of TUDE will drive any material moves. Historical analogs show mixed HSCS-like events often lead to range-bound trading until clear post-close metrics emerge.
HSCS faces near-term ambiguity ahead of the H2 2026 close; post-close, HSCS holders gain a TUDE stake but with limited upside unless TUDE re-rates meaningfully.
Category: M&A. The cross-industry deal combines a crypto venture miner with a medical tech AI company, signaling strategic reallocation and capital-market expansion for DCG-backed Fortitude and HSCS, with near-term closing risk and long-term valuation questions tied to ZEC exposure.